- $1.23m
- -$8.23m
- $0.67m
Brief: Vyant Bio Announces Issuance Of Key Patent For High-Throughput Optical Assay Of Human Mixed Cell Population Spheroids
Brief: Vyant Bio Posts Q1 Loss Per Share Of $2.31
Cancer Genetics: Jumps after shareholders approve merger with biotech start-up
Brief: Cancer Genetics Announces Shareholder Approval
U.S. STOCKS ON THE MOVE-Shutterstock, Tilray, Zillow, Cancer Genetics, Spirit Airlines
U.S. STOCKS ON THE MOVE-Zynga, Kraft Heinz, Molson Coors, Hexo, Cancer Genetics
U.S. STOCKS ON THE MOVE-Shutterstock, Tilray, Tyson Foods, Crypto stocks
U.S. STOCKS ON THE MOVE-Zynga, Spirit Airlines, Pinterest, Crypto stocks
U.S. STOCKS ON THE MOVE-Spirit Airlines, Pinterest, Novavax, Zynga
Cancer Genetics: Slumps on $17.5 mln equity offering
Brief: Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-The-Market Under Nasdaq Rules
Brief: Cancer Genetics Files Prospectus Related To Resale Of Upto 5.7 Million Shares Of Common Stock, Including Stock Issuable On Exercise Of Warrants - SEC Filing
Brief: Cancer Genetics Announces $10.0 Million Private Placement Priced At-The-Market
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:46 PM
Brief: Cancer Genetics - On January 4, Got Notice From Nasdaq Notifying Co That It No Longer Complies With Nasdaq Listing Rule
U.S. STOCKS ON THE MOVE-Tesla, Kodak, Cancer Genetics, ON Semiconductor
Brief: Cancer Genetics Filed Prospectus Supplement Related To Offering Of Up To $2.4 Million Of Common Stock
Brief: Cancer Genetics Reports Q3 2020 Financial Results
U.S. STOCKS ON THE MOVE-Tricida, Cancer Genetics, Penumbra Inc